News Novo aims for GLP-1 sales growth in China Novo expects Victoza and semaglutide to gain momentum.
Views & Analysis Pharma partners with African countries on chronic diseases An innovative programme is being rolled out across Kenya.
News Takeda preps for further acquisition Japanese firm has set money aside for emerging markets M&A.
Views & Analysis Going beyond CSR to reach ‘the two billion’ Impact of putting access to medicine at the core of pharma businesses.
Views & Analysis Disrupting healthcare: 4 lessons from emerging markets Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
News GSK settles US bribery probe for $20m Actions of Chinese subsidiaries violated US bribery laws, says SEC.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
